Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination

Abstract

To provide quantitative insight into current U.S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease.